News

Top Stories

ALS: Treatment for One Opens Door for Others

Source:

Columbia Medicine Magazine

Dr. Neil Shneider, MD, PhD, director of the Eleanor and Lou Gehrig ALS Center, requested a one-time experimental therapy treatment through the FDA which has evolved into a multicenter clinical trial.

Topic

Research
Families Pursue Clinical Trials for Ultra Rare Diseases

Patients at Columbia are pursuing custom-designed ASO therapies. These compounds lend themselves to personalization.
Wings Over Wall Street Honors Dr. Neil Shneider with Diamond Award

Wings over Wall Street gala for the MDA research program on ALS honored Dr. Shneider with the Diamond Award. In recognition of his scientific leadership and dedication to the eradication of ALS.
Today Show Interview With Dr. Neil Shneider

Source:

Today Show

See Dr. Shneider's interview with Today show reflecting on the efforts to find a cure and treatments through the continued work of our team at the Columbia Eleanor & Lou Gehrig ALS Center.

The ALS Association Launches Project Revoice

January 5, 2019

Project Revoice aims to help those living with ALS with recording and recreating their natural voices for future use.
Eleanor and Lou Gehrig Center Opens New Location in Tarrytown, NY

March 2, 2018

We are excited to announce the opening of a new office location at Columbia Doctors located at 155 White Plains Rd, Tarrytown, NY 10591.
FDA Approves Drug to Treat ALS

Source:

U.S. Food and Drug Administration Newsroom

May 5, 2017

The FDA released information regarding the recent approval of a new intravenous infusion called Radicava, also known as Edaravone.